跳至主要内容
临床试验/DRKS00026785
DRKS00026785已完成未知

Children’s Health InterventionaL Trial III - CHILT III

Deutsche Sporthochschule Köln, Institut für Bewegungs- und Neurowissenschaften, Abteilung Bewegungs- und Gesundheitsförderung0 个研究点目标入组 134 人开始时间: 2021年10月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
134

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
8 Years 至 16 Years(—)
性别
All

入选标准

  • Children aged 8- including 16 years and their parents.
  • -The participant's BMI exceeds the 97th percentile and/or either a) obesity-associated risk factors or b) obesity-associated diseases are present
  • -Sufficient German language skills of the children and parents
  • -Sufficient motivation of the children and parents to actively participate in the training course.
  • -Normal ability to attend school
  • -The previous outpatient medical treatment according to the currently available guideline recommendation (e.g. AGA) was unsuccessful.

排除标准

  • -Psychological disorder or illness (e.g. eating disorder, bulimia).
  • -lack of motivation on the part of the children or their parents
  • -Inadequate group ability
  • -Adiposity due to a medical condition (e.g., Prader-Willi syndrome)
  • -lack of written consent

研究者

发起方
Deutsche Sporthochschule Köln, Institut für Bewegungs- und Neurowissenschaften, Abteilung Bewegungs- und Gesundheitsförderung

相似试验

已完成
不适用
A nutrition intervention research project for low-income mothers of toddlersDiet and Nutrition - ObesityObesity
ACTRN12610000981022Susan Baker600
进行中(未招募)
不适用
Immunogenicity and Safety Study of a Hexavalent DTaP-IPV-HB-Hib Combined Vaccine in a 3-dose Primary Series in Healthy Infants in EuropePrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infection caused by hepatitis B virusMedDRA version: 14.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2012-001055-39-ESSanofi Pasteur SA795
进行中(未招募)
不适用
Immunogenicity and Safety Study of a Hexavalent DTaP-IPV-HB-Hib Combined Vaccine in a 3-dose Primary Series in Healthy Infants in EuropePrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infection caused by hepatitis B virusMedDRA version: 17.0Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2012-001055-39-CZSanofi Pasteur SA795
进行中(未招募)
不适用
Immunogenicity and Safety Study of a Hexavalent DTaP-IPV-HB-Hib Combined Vaccine in a 3-dose Primary Series in Healthy Infants in EuropePrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infection caused by hepatitis B virusMedDRA version: 17.0Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 17.0Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2012-001055-39-DESanofi Pasteur SA795
进行中(未招募)
不适用
Antibody Persistence in Healthy South African Children After Primary Series and Booster Vaccination with an Investigational(DTaP-IPV-Hep B-PRP-T) or Control VaccinesPrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus type 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infections caused by hepatitis B virusMedDRA version: 14.1Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2011-004450-26-Outside-EU/EEASanofi Pasteur SA567